Background. Persistent nasal carriers have an increased risk of Staphylococcus aureus
infection, whereas intermittent carriers and noncarriers share the same low risk. This study …

To increase testing of vaccine induced humoral immunity in immune surveillance studies
and vaccine trials, a rapid and simple microsphere-based multiplex assay (pentaplex) was …

Background Persistent carriers have a higher risk of Staphylococcus aureus infections than
noncarriers but a lower risk of bacteremia-related death. Here, the role played by anti …

A spectrum-resolved dual-color electrochemiluminescence (ECL) immunoassay was
designed and implemented to simultaneously detect carcinoembryonic antigen (CEA) and …

Group A streptococcus (GAS) is known to cause a broad spectrum of illness, from
pharyngitis and impetigo, to autoimmune sequelae such as rheumatic heart disease, and …

Attempts to develop an efficient anti-staphylococcal vaccine in humans have so far been
unsuccessful. Therefore, more knowledge of the antigens that are expressed by …

Expanding knowledge on the humoral immune response in Staphylococcus aureus-infected
patients is a mandatory step in the development of vaccines and immunotherapies. Here, we …

Background & Aim The ability of Staphylococcus aureus to successfully colonize (a) biotic
surfaces may be explained by biofilm formation and the actions of virulence factors. The aim …

For the first time, we have engineered streptavidin labeled fluorescent silver nanoparticles
for their application in immunosensing of biomolecules which will significantly increase …

Abstract Background Toxins are important Staphylococcus aureus virulence factors, but little
is known about their immunogenicity during infection. Here, additional insight is generated …